Ensuring that clinical tests are not affected by tumor heterogeneity requires a sampling methodology that captures the genomic, proteomic, and cellular diversity of entire solid tumors. However, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback